# Nektar Therapeutics: Form 8-K, filed Dec 16, 2025

- Company: [Nektar Therapeutics](/companies/nktr.md) (CIK 906709)
- Form: 8-K
- Filed: 2025-12-16
- Accepted by EDGAR: Dec 16, 2025, 08:00 ET
- Period: 2025-12-16
- Accession: 0001193125-25-320009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906709/000119312525320009/d24251d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906709/000119312525320009/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/906709/000119312525320009/d24251d8k.htm

Filed Dec 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-320009. Last ingested by Listed: Nov 14, 2026, 10:52 ET. No prices; not investment advice.
